43.67
Livanova Plc 주식(LIVN)의 최신 뉴스
What is LivaNova PLC company’s growth strategyRobust investment performance - jammulinksnews.com
Why is LivaNova PLC stock attracting strong analyst attentionCapitalize on strong market momentum - jammulinksnews.com
What is the risk reward ratio of investing in LivaNova PLC stockMaximize your gains with professional insights - jammulinksnews.com
When is LivaNova PLC stock expected to show significant growthGet real-time alerts on top stocks - jammulinksnews.com
What makes LivaNova PLC stock price move sharplyFree Access to Community - beatles.ru
Why LivaNova PLC stock attracts strong analyst attention10x Return With Managed Risk - Metal.it
LivaNova’s VNS Therapy Shows Sustained Effectiveness in Drug-Resistant Epilepsy - Insider Monkey
Will LivaNova PLC stock benefit from interest rate changesFree Risk Assessment Services - jammulinksnews.com
How CPBI stock compares to its top competitorsIs LivaNova PLC stock undervalued or overvalued nowMarket-beating performance - jammulinksnews.com
Is LivaNova PLC a good long term investmentUnprecedented market success - PrintWeekIndia
What analysts say about LivaNova PLC stockMarket-leading capital gains - Autocar Professional
External Pacemakers Market Set to Witness Significant Growth - openPR.com
What drives LivaNova PLC stock priceBreakthrough financial growth - Autocar Professional
LivaNova PLC Stock Analysis and ForecastAccelerated wealth expansion - Autocar Professional
Cardiac Autonomic Control Market Growth in Future Scope - openPR.com
In-Line Blood Monitoring Devices Market is projected to grow - openPR.com
Wearable Cardioverter Defibrillators Market is projected - openPR.com
Jefferies Reiterates a Buy Rating on LivaNova PLC (LIVN) With a $79 PT - MSN
Neuro Modulation Devices Market is expected to reach US$ 7.6 - openPR.com
(LIVN) Technical Data - news.stocktradersdaily.com
‘A vicious life loop’: Epilepsy community calls for action to address the burden of disease - medianet.com.au
자본화:
|
볼륨(24시간):